Volume | 2,000 |
|
|||||
News | - | ||||||
Day High | 0.015 | Low High |
|||||
Day Low | 0.015 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Protokinetix Inc (PK) | PKTX | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.015 | 0.015 | 0.015 | 0.015 | 0.01504 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1 | 2,000 | $ 0.015 | $ 30 | - | 0.0101 - 0.03 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:58:04 | 2,000 | $ 0.015 | USD |
Protokinetix Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.39M | 335.63M | - | 0 | -415k | -0.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Protokinetix (PK) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PKTX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0142 | 0.0153 | 0.0112 | 0.0138584 | 48,496 | 0.0008 | 5.63% |
1 Month | 0.0136 | 0.0167 | 0.0112 | 0.0142468 | 65,131 | 0.0014 | 10.29% |
3 Months | 0.016 | 0.0199 | 0.0112 | 0.0161217 | 100,316 | -0.001 | -6.25% |
6 Months | 0.0136 | 0.0289 | 0.0102 | 0.0173038 | 126,442 | 0.0014 | 10.29% |
1 Year | 0.0203 | 0.03 | 0.0101 | 0.0192353 | 106,309 | -0.0053 | -26.11% |
3 Years | 0.1302 | 0.1888 | 0.0101 | 0.0414351 | 83,285 | -0.1152 | -88.48% |
5 Years | 0.18 | 0.32 | 0.0101 | 0.099126 | 92,209 | -0.165 | -91.67% |
Protokinetix (PK) Description
ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever. |